Comments
Loading...
CytomX Therapeutics (NASDAQ:CTMX) Stock, Earnings Estimates, EPS, And Revenue
CytomX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-0.130
Quarterly Revenue Estimate
$13.53M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$126.62M
Analyze the earnings history of CytomX Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
CytomX Therapeutics (CTMX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $0.07 | $-0.17 | 141.2 % |
| Q2 | 2024-08-08 | $-0.08 | $-0.14 | 42.9 % |
| Q1 | 2024-05-08 | $0.17 | $-0.06 | 383.3 % |
| Q4 | 2024-03-11 | $0.01 | $-0.03 | 133.3 % |
CytomX Therapeutics (CTMX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $33.43M | $17.51M | 90.9 % |
| Q2 | 2024-08-08 | $25.12M | $19.99M | 25.6 % |
| Q1 | 2024-05-08 | $41.46M | $22.02M | 88.3 % |
| Q4 | 2024-03-11 | $26.61M | $21.04M | 26.5 % |
FAQ
When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?
CytomX Therapeutics (CTMX) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for CytomX Therapeutics (NASDAQ:CTMX)?
The Actual EPS was $0.07, which beat the estimate of $-0.17.
What were CytomX Therapeutics’s (NASDAQ:CTMX) revenues?
The Actual Revenue was $33.4M, which beat the estimate of $17.5M.
Browse earnings estimates, EPS, and revenue on all stocks.